Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 14975603 | HLA-CLASS I (HLA-I) | relapsing-remitting multiple sclerosis | NA | NA | NA | positive | |
| beneficial effect of interferon-beta 1b treatment in patients with relapsing-remitting multiple sclerosis is associated with an increase in serum levels of soluble hla-i molecules during the first 3 months of therapy. | |||||||
| 17997167 | HLA-G (HLA-G) | relapsing-remitting multiple sclerosis | NA | NA | NA | negation | |
| soluble hla-g molecules are released as hla-g5 and not as soluble hla-g1 isoforms in csf of patients with relapsing-remitting multiple sclerosis. | |||||||
| 17997167 | HLA (HLA) | relapsing-remitting multiple sclerosis | NA | NA | NA | unclassified | |
| cerebrospinal fluid (csf) levels of shla-g (shla-g1/hla-g5) molecules and their soluble isoforms hla-g5 and shla-g1 were measured by elisa procedures in 68 relapsing-remitting multiple sclerosis (rr ms) patients, in 67 patients with other inflammatory neurological disorders (oind) and in 70 subjects with non-inflammatory neurological disorders (nind). | |||||||
| 17997167 | HLA (HLA) | neurological disorders | NA | NA | NA | unclassified | |
| cerebrospinal fluid (csf) levels of shla-g (shla-g1/hla-g5) molecules and their soluble isoforms hla-g5 and shla-g1 were measured by elisa procedures in 68 relapsing-remitting multiple sclerosis (rr ms) patients, in 67 patients with other inflammatory neurological disorders (oind) and in 70 subjects with non-inflammatory neurological disorders (nind). | |||||||
| 18208868 | HLA-G (HLA-G) | relapsing-remitting multiple sclerosis | NA | NA | NA | unclassified | |
| csf levels of soluble hla-g and fas molecules are inversely associated to mri evidence of disease activity in patients with relapsing-remitting multiple sclerosis. | |||||||
| 27020477 | HLA (HLA) | relapsing-remitting multiple sclerosis | NA | NA | NA | unclassified | |
| hla genes as modifiers of response to ifn-b-1a therapy in relapsing-remitting multiple sclerosis. | |||||||
| 27020477 | HLA (HLA) | relapsing-remitting multiple sclerosis | NA | NA | NA | only_studied | |
| aimsthis study investigated the influence of hla class-i and -ii genes in the response to ifn-b in relapsing-remitting multiple sclerosis (ms) patients. | |||||||
| 9778959 | HLA (HLA) | glucose | NA | glucagon | NA | unclassified | |
| NA | |||||||
| 23020308 | HLA-B (HLA-B) | hashimoto's disease | Chinese Han | NA | NA | unclassified | |
| the hla-b gene and hashimoto disease in han chinese children: a case-control and family-based study. | |||||||
| 32510303 | HLA-CLASS I (HLA-I) | molluscum contagiosum | NA | NA | NA | negative | |
| downregulation of hla-i by the molluscum contagiosum virus mc080 impacts nk-cell recognition and promotes cd8+ t-cell evasion. | |||||||
Copyright 2024